Atlas Trials

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease

Clinical trial NCT00269854 · COMPLETED

Trial details

NCT number
NCT00269854
Sponsor
Centocor, Inc.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Crohn Disease
Start date
1995-06-01
Primary completion
1996-10-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.